Cargando…

Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program

OBJECTIVE: To examine associations between dietary intake of omega‐3 (n‐3; generally antiinflammatory) and omega‐6 (n‐6; generally proinflammatory) fatty acids and patient‐reported outcomes in systemic lupus erythematosus (SLE). METHODS: This study was based on the population‐based Michigan Lupus Ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Charoenwoodhipong, Prae, Harlow, Sioban D., Marder, Wendy, Hassett, Afton L., McCune, W. Joseph, Gordon, Caroline, Helmick, Charles G., Barbour, Kamil E., Wang, Lu, Mancuso, Peter, Somers, Emily C., Zick, Suzanna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842394/
https://www.ncbi.nlm.nih.gov/pubmed/31074595
http://dx.doi.org/10.1002/acr.23925
_version_ 1783468040485076992
author Charoenwoodhipong, Prae
Harlow, Sioban D.
Marder, Wendy
Hassett, Afton L.
McCune, W. Joseph
Gordon, Caroline
Helmick, Charles G.
Barbour, Kamil E.
Wang, Lu
Mancuso, Peter
Somers, Emily C.
Zick, Suzanna M.
author_facet Charoenwoodhipong, Prae
Harlow, Sioban D.
Marder, Wendy
Hassett, Afton L.
McCune, W. Joseph
Gordon, Caroline
Helmick, Charles G.
Barbour, Kamil E.
Wang, Lu
Mancuso, Peter
Somers, Emily C.
Zick, Suzanna M.
author_sort Charoenwoodhipong, Prae
collection PubMed
description OBJECTIVE: To examine associations between dietary intake of omega‐3 (n‐3; generally antiinflammatory) and omega‐6 (n‐6; generally proinflammatory) fatty acids and patient‐reported outcomes in systemic lupus erythematosus (SLE). METHODS: This study was based on the population‐based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n‐3 and n‐6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient‐reported outcomes included self‐reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n‐3 and n‐6, as well as the n‐6:n‐3 ratio, and patient‐reported outcomes. RESULTS: Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean ± SD age was 52.9 ± 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6; P = 0.013) with each unit increase of the n‐6:n‐3 ratio. Both lupus activity and Patient‐Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1‐gram/1,000 kcal increase of n‐3 fatty acids (SLAQ regression coefficient β = –0.8 [95% CI –1.6, 0.0]; P = 0.055; PROMIS sleep β = –1.1 [95% CI –2.0, –0.2]; P = 0.017). Higher n‐3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction. CONCLUSION: This population‐based study suggests that higher dietary intake of n‐3 fatty acids and lower n‐6:n‐3 ratios are favorably associated with patient‐reported outcomes in SLE, particularly self‐reported lupus activity and sleep quality.
format Online
Article
Text
id pubmed-6842394
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68423942020-07-28 Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program Charoenwoodhipong, Prae Harlow, Sioban D. Marder, Wendy Hassett, Afton L. McCune, W. Joseph Gordon, Caroline Helmick, Charles G. Barbour, Kamil E. Wang, Lu Mancuso, Peter Somers, Emily C. Zick, Suzanna M. Arthritis Care Res (Hoboken) Systemic Lupus Erythematosus OBJECTIVE: To examine associations between dietary intake of omega‐3 (n‐3; generally antiinflammatory) and omega‐6 (n‐6; generally proinflammatory) fatty acids and patient‐reported outcomes in systemic lupus erythematosus (SLE). METHODS: This study was based on the population‐based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n‐3 and n‐6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient‐reported outcomes included self‐reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n‐3 and n‐6, as well as the n‐6:n‐3 ratio, and patient‐reported outcomes. RESULTS: Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean ± SD age was 52.9 ± 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6; P = 0.013) with each unit increase of the n‐6:n‐3 ratio. Both lupus activity and Patient‐Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1‐gram/1,000 kcal increase of n‐3 fatty acids (SLAQ regression coefficient β = –0.8 [95% CI –1.6, 0.0]; P = 0.055; PROMIS sleep β = –1.1 [95% CI –2.0, –0.2]; P = 0.017). Higher n‐3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction. CONCLUSION: This population‐based study suggests that higher dietary intake of n‐3 fatty acids and lower n‐6:n‐3 ratios are favorably associated with patient‐reported outcomes in SLE, particularly self‐reported lupus activity and sleep quality. John Wiley and Sons Inc. 2020-06-29 2020-07 /pmc/articles/PMC6842394/ /pubmed/31074595 http://dx.doi.org/10.1002/acr.23925 Text en © 2019, The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Systemic Lupus Erythematosus
Charoenwoodhipong, Prae
Harlow, Sioban D.
Marder, Wendy
Hassett, Afton L.
McCune, W. Joseph
Gordon, Caroline
Helmick, Charles G.
Barbour, Kamil E.
Wang, Lu
Mancuso, Peter
Somers, Emily C.
Zick, Suzanna M.
Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
title Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
title_full Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
title_fullStr Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
title_full_unstemmed Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
title_short Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
title_sort dietary omega polyunsaturated fatty acid intake and patient‐reported outcomes in systemic lupus erythematosus: the michigan lupus epidemiology and surveillance program
topic Systemic Lupus Erythematosus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842394/
https://www.ncbi.nlm.nih.gov/pubmed/31074595
http://dx.doi.org/10.1002/acr.23925
work_keys_str_mv AT charoenwoodhipongprae dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT harlowsioband dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT marderwendy dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT hassettaftonl dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT mccunewjoseph dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT gordoncaroline dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT helmickcharlesg dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT barbourkamile dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT wanglu dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT mancusopeter dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT somersemilyc dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram
AT zicksuzannam dietaryomegapolyunsaturatedfattyacidintakeandpatientreportedoutcomesinsystemiclupuserythematosusthemichiganlupusepidemiologyandsurveillanceprogram